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Emerging evidence has shown that noncoding
RNAs, particularly microRNAs (miRNAs), contribute
to the pathogenesis of mood and anxiety disorders,
although the molecular mechanisms are poorly un-
derstood. Here, we show that altered levels of miR-
17-92 in adult hippocampal neural progenitors have
a significant impact on neurogenesis and anxiety-
and depression-related behaviors in mice. miR-17-
92 deletion in adult neural progenitors decreases
neurogenesis in the dentate gyrus, while its overex-
pression increases neurogenesis. miR-17-92 affects
neurogenesis by regulating genes in the glucocorti-
coid pathway, especially serum- and glucocorti-
coid-inducible protein kinase-1 (Sgk1). miR-17-92
knockout mice show anxiety- and depression-like
behaviors, whereas miR-17-92 overexpressing mice
exhibit anxiolytic and antidepression-like behaviors.
Furthermore, we show that miR-17-92 expression in
the adult mouse hippocampus responds to chronic
stress, and miR-17-92 rescues proliferation defects
induced by corticosterone in hippocampal neural
progenitors. Our study uncovers a crucial role for
miR-17-92 in adult neural progenitors through regu-
lation of neurogenesis and anxiety- and depres-
sion-like behaviors.INTRODUCTION
Mood and anxiety disorders are known to be associated with
many risk factors, such as environmental, genetic, and epige-
netic ones, making investigation of the pathophysiology of these
disorders extremely challenging (Krishnan and Nestler, 2008).
Antidepressants are used for the treatment of both depression
and anxiety disorders, but only 30%–50% of patients show
amelioration (Gaynes et al., 2008). Thus, it is essential to betterCell
This is an open access article under the CC BY-Nunderstand the etiology of the disorders and to develop new tar-
gets for improved therapies.
The dentate gyrus (DG) in the hippocampus is one of the neuro-
genic zones in the adult brain. TheDG is populatedby neural stem
cells and neural progenitors and is continuously generating new
neurons (Ming and Song, 2011; Zhao et al., 2008). The impact
of adult neurogenesis in the function of hippocampus has drawn
significant attention (Deng et al., 2010; Jacobs et al., 2000; Kheir-
bek et al., 2012; Sahay and Hen, 2007). While some studies
demonstrate the association of adult neurogenesis with depres-
sion and anxiety (Kheirbek et al., 2012; Sahay and Hen, 2007),
other reports show inconsistent outcomes (Petrik et al., 2012).
Even though the neurogenic theory of depression and anxiety ap-
pears controversial, it is still plausible and holds possibility for the
adult hippocampal neurogenesis as a therapeutic means for
mood and anxiety disorders (Eisch and Petrik, 2012; Hill et al.,
2015; Miller and Hen, 2015). Thus, there is an unmet need for
research to identify molecules that regulate both hippocampal
neurogenesis and depression- and anxiety-like behaviors.
MicroRNAs (miRNAs) normally silence protein-coding target
genes and play crucial roles in many aspects of neural develop-
ment and neurological disorders (Bian and Sun, 2011; Fineberg
et al., 2009; Kosik, 2006; Qureshi and Mehler, 2012). Recent
studies have begun to reveal the contribution of miRNAs in the
pathogenesis of mood and anxiety disorders (Issler et al.,
2014; Lopez et al., 2014; Malan-M€uller et al., 2013; Xu et al.,
2012). However, little is known about specific miRNAs being
involved in the regulation of adult hippocampal neurogenesis
and/or mood and anxiety behaviors.
The miR-17-92 cluster has been shown to be involved in em-
bryonic brain development and tumorigenesis (Bian et al., 2013;
Olive et al., 2010). In this study, we identified themiR-17-92 clus-
ter highly expressed in the adult mouse hippocampus. We found
that miR-17-92 regulates adult hippocampal neurogenesis
and mood and anxiety-related behaviors in mice. We further
established the regulatory role of miR-17-92 in modifying genes
in the glucocorticoid pathway including Sgk1 and rescuing
reduced proliferation, caused by corticosterone, in hippocampal
progenitors. Our studies indicate that the miR-17-92 cluster
is a pivotal regulator of adult hippocampal neurogenesis and
anxiety- and depression-like behaviors.Reports 16, 1653–1663, August 9, 2016 ª 2016 The Authors. 1653
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Altering Adult Hippocampal Expression of miR-17-92 in miR-17-92 KO and OE Mice
(A) Schematic genomic organization of miRNAs in the miR-17-92 cluster on mouse chromosome 14. The color code represents miRNAs with the conserved seed
sequence.
(B) miR-17 (miR-20a), miR-19a (miR-19b), and miR-92a were expressed in the 12-week-old adult mouse hippocampus (Hp) and cortex (Cx).
(C and D) Generation of miR-17-92 knockout (KO) and miR-17-92 overexpressing (OE) mice using the Nestin-CreER line.
(E) The whole brain images of wild-type (WT), miR-17-92 KO, and miR-17-92 OE mice at 13 weeks of age.
(F) The bodyweight ofmiR-17-92 KOwas slightly reduced, and the bodyweight ofmiR-17-92OEmicewas not changed, compared toWT controls. Brain weights
of miR-17-92 KO and miR-17-92 OE mice were indistinguishable from WT controls.
Values plotted were means ±SEM, n = 6mice per group. *p < 0.05. A two-tailed, unpaired Student’s t test was used for comparisons. See also Figures S1 and S2.RESULTS
Altering Adult Hippocampal Expression of miR-17-92 in
miR-17-92 KO and OE Mice
Previous studies suggested a role of the miR-17-92 cluster in
embryonic neural stem cell development and proliferation of
cancer cells (Bian et al., 2013; Olive et al., 2010), but its
involvement in adult brain neurogenesis and function is un-
known. Transcription of the miR-17-92 cluster generates six
miRNAs that can be grouped into four subfamilies (Mendell,
2008), miR-17 (and miR-20a), miR-18a, miR-19a (and miR-
19b), and miR-92a, based on their conserved sequences (Fig-
ure 1A). To examine expression patterns of miR-17-92, we
performed in situ hybridization in 12-week-old adult mouse
brains by using locked nucleic acid (LNA) probes for miR-17
(that also recognizes 20a), miR-19a (that also recognizes
19b), and miR-92a. All three subfamilies of the miRNA were
expressed in the adult hippocampus and in the cortex
(Figure 1B).1654 Cell Reports 16, 1653–1663, August 9, 2016BecausemiR-17-92 has been shown to regulate proliferation in
embryonic neural stem cells and cancer cells (Bian et al., 2013;
Olive et al., 2010), we speculated that they might be involved in
adult hippocampal neurogenesis and function. To examine
the possible role for miR-17-92 in maintaining progenitor cells in
the adult hippocampus, we generated conditional miR-17-92
knockout (miR-17-92 KO) mice and miR-17-92 overexpressing
(miR-17-92 OE) mice. We utilized a Nestin-CreER line (Kuo
et al., 2006), in which the Cre recombinase is expressed in neural
progenitors in the adult brain upon tamoxifen injection. The Nes-
tin-CreER mice were bred with floxed miR-17-92 KO mice (Ven-
tura et al., 2008) or floxed miR-17-92 overexpressing mice (Xiao
et al., 2008), and tamoxifen was injected at the age of 5 weeks
(Figures 1C, 1D, and S1A). To test altered miR-17-92 expression,
real-time qRT-PCR was performed. Expression levels of miR-17,
miR-18,miR-19a, andmiR-92were decreased in hippocampus of
miR-17-92 KO mice, while they were increased in hippocampus
of miR-17-92 OE mice, suggesting expected alteration of miR-
17-92 in the adult hippocampus (Figures S2A and S2B).
Figure 2. Deletion or Overexpression of
miR-17-92 in Adult Neural Progenitors
Causes Altered Hippocampal Neurogenesis
(A and B) The number of BrdU+ (red) proliferating
cells was decreased in the dentate gyrus (DG) of
13-week-old miR-17-92 knockout (KO) mice,
compared to wild-type (WT) mice. Scale bar,
100 mm.
(C and D) The number of BrdU+ cells was signifi-
cantly increased in miR-17-92 overexpressing
(OE) mice. Scale bar, 100 mm.
(E and F) The number of Ki67+ (green) progenitors
in the DG was significantly reduced in 13 weeks
old miR-17-92 KO mice. Scale bar, 100 mm.
(G and H) The number of Ki67+ cells was signifi-
cantly increased in OE mice compared to WT.
Scale bar, 100 mm.
(I and J) Deletion of miR-17-92 led to significant
reduction in the number of Dcx+ neurons (red) in
the DG.
(K and L) The number of Dcx+ cells was increased
in OE mice. Scale bars, 20 mm.
DAPI (blue) was used to label nucleus. All data
were presented as means ± SEM, n = 6 mice per
group. *p < 0.05, ***p < 0.001. A two-tailed, un-
paired Student’s t test was used for comparisons.
See also Figures S1 and S3.miR-17-92 KO andOEmice showed normal brain morphology
(Figure 1E). In addition, miR-17-92 KO mice displayed slightly
reduced body weight but normal brain weight compared to
wild-type control littermates (Figure 1F). miR-17-92 OE mice
were indistinguishable from controls in brain and body weights
(Figure 1F). Furthermore, we measured the thickness of the
cortical wall and found no difference among control, miR-17-
92 KO, and OE mice (Figures S2C–S2E). These results suggest
that altered miR-17-92 expression in neural progenitors in the
adult brain has minimal effects on brain and body growth.
Adult Hippocampal Neurogenesis Is Altered in
miR-17-92 KO and OE Mice
Even though brain weights were not changed in miR-17-92 KO
and OE mice, altered miR-17-92 expression might affect neuro-
genesis in the adult hippocampus. We thus investigated gener-
ation of adult hippocampal neural progenitors and newborn
neurons in miR-17-92 KO and OE mice. To detect proliferative
neural progenitors, bromodeoxyuridine (BrdU) was administered
in the 12-week-old mice, 6 days before brain tissue collection
(Figure S1A). The number of BrdU+ cells was reduced in the den-
tate gyrus of the miR-17-92 KO hippocampus (Figures 2A and
2B), but increased in OE mice (Figures 2C and 2D). Moreover,
the number of cells expressing Ki67, which indicates progenitors
in the G1, S, G2, and M phases of the cell cycle, also was
decreased in the miR-17-92 KO (Figures 2E and 2F) but
increased in theOE hippocampus (Figures 2G and 2H). These re-
sults indicate that miR-17-92 function is required for maintaining
proliferative neural progenitors in the adult hippocampus.
We also examined the number of Doublecortin (Dcx)-express-
ing newborn neurons. Consistent with changes in the number ofneural progenitors, the number of Dcx+ cells was reduced in the
DG of the miR-17-92 KO hippocampus (Figures 2I and 2J), but
increased in OE mice (Figures 2K and 2L), suggesting that gen-
eration of newborn neurons is impaired.Moreover, the number of
BrdU+ or NeuN+/BrdU+ cells at 13weeks old, whichwere labeled
by BrdU injection at 7 weeks old to detect newborn neurons (Fig-
ure S1B), also was decreased in the miR-17-92 KO hippocam-
pus (Figures S3A and S3B). Taken together, our results indicate
that miR-17-92 is required to maintain proliferative neural pro-
genitors and to generate new neurons in the adult hippocampus.
miR-17-92KO andOEMiceExhibit ElevatedAnxiety-like
or Anti-anxiety-like Behaviors
Previous studies have shown that adult hippocampal neurogen-
esis is associated with mood and anxiety disorders (Eisch and
Petrik, 2012; Miller and Hen, 2015). Because altered expression
ofmiR-17-92 caused changes in hippocampal neurogenesis, we
examinedwhether anxiety-related behaviors are affected inmiR-
17-92 KO and OEmice (Figure S1C). In the open field test, miR-
17-92 KOmice andOEmice showed comparable locomotor ac-
tivity as measured by total distance compared to their wild-type
controls (Figure S3C). However, miR-17-92 KO mice displayed
markedly less frequency of stay, less time spent, and less dis-
tance moved in the center of the open field compared to wild-
type controls (Figure 3A). On the other hand, miR-17-92 OE
mice exhibited opposing behaviors (Figure 3B). Moreover, in
the elevated plus maze test,miR-17-92 KOmice showed signif-
icantly less duration and less distance traveled in open arms (Fig-
ure 3C), whilemiR-17-92 OEmice showed a significantly greater
frequency of stay and longer total distance moved in open arms
(Figure 3D). These results indicate that miR-17-92 deletion orCell Reports 16, 1653–1663, August 9, 2016 1655
Figure 3. Deletion or Overexpression of the miR-17-92 Cluster in Adult Neural Progenitors Results in Altered Anxiety- and Depression-like
Behaviors
(A) miR-17-92 knockout (KO) mice displayed less frequency, duration, and distance moved in the center in the open field, compared to wild-type (WT) mice.
(B) miR-17-92 overexpressing (OE) mice showed significantly anxiolytic behavior in the open field test.
(C) miR-17-92 KO mice showed less duration and distance traveled in open arms in the elevated plus maze test.
(D) miR-17-92 OE mice showed significantly increased frequency and total distance moved in open arms in the elevated plus maze test.
(E)miR-17-92 KOmice showed significantly elevated immobility time in the forced swim test, compared toWTmice. Results are shown as themean of immobility
duration (seconds).
(F) miR-17-92 KO mice showed increased immobility in the tail suspension test. Results are shown as the mean of immobility duration (seconds).
(G) miR-17-92 KO mice showed significantly reduced sucrose consumption in the sucrose preference test, compared to WT mice. Results are shown as the
percentage of sucrose consumption ratio (% of WT).
(H) miR-17-92 OE mice had significantly reduced immobility time compared to WT mice in the forced swim test.
(I) miR-17-92 OE mice showed reduced immobility in the tail suspension test.
(J) miR-17-92 OE mice showed no difference in the sucrose preference test.
Values plotted are means ± SEM, n = 13–18 mice per group. *p < 0.05, **p < 0.01. A two-tailed, unpaired Student’s t test was used for comparisons. See also
Figure S3.overexpression in mice results in elevated anxiety-like or anti-
anxiety-like behaviors, respectively.
Altered Expression of miR-17-92 in the Hippocampus
Regulates Depression-like Behaviors
Adult hippocampal neurogenesis has been shown to be related
to depression (Sahay and Hen, 2007), we also examined depres-
sion-like behaviors in miR-17-92 KO and OE mice. In the forced
swim test,miR-17-92 KOmice displayed significantly increased1656 Cell Reports 16, 1653–1663, August 9, 2016immobility time (Figure 3E). In the tail-suspension test, the immo-
bility time was also increased inmiR-17-92 KOmice, suggesting
thatmiR-17-92 KOmice exhibit elevated depression-like behav-
iors (Figure 3F). Moreover, in the sucrose preference test, miR-
17-92 KO mice showed reduced intake of sucrose, suggesting
anhedonia-like behavior (Figure 3G). Conversely, in both the
forced swim and tail-suspension tests, miR-17-92 OE mice
had greatly reduced immobility time, compared to their controls,
suggesting an antidepression-like effect of miR-17-92 (Figures
Figure 4. Deletion of miR-17-92 in Adult Hippocampal Neural Progenitors Alters Expression Levels of Genes in the Glucocorticoid Pathway
(A) Schematic flow of gene expression analysis. The adult hippocampal samples from 12-week-old wild-type (WT) and miR-17-92 knockout (KO) mice were
analyzed by RNA-sequencing to detect genes with altered expression.
(B) Gene ontology (GO) analysis of 150 predicted target genes indicated tenmost significantly overrepresented functions. The glucocorticoid-mediated signaling
pathway was the top among altered functions.
(C) Gene ontology analysis of signaling pathways associated with the Sgk1 function. See details in the Experimental Procedures.
See also Figure S4.3H and 3I). In sucrose preference test, miR-17-92 OE mice
did not show detectable difference compared to controls (Fig-
ure 3J). These results altogether indicate that miR-17-92 deletion
or overexpression in the adult neural progenitors results in
increased or decreased anxiety- and depression-like behaviors.
The Glucocorticoid Pathway Is Affected inmiR-17-92
KO Hippocampus
miRNAs exert their functions by silencing target genes. To inves-
tigate miR-17-92 regulation mechanisms, we next quantified
gene expression levels in the hippocampus of miR-17-92 KO
and wild-type mice using Illumina RNA-sequencing (RNA-seq)
to identify genes with altered expression when miR-17-92 is
knocked out (Figures 4A and S1D). We identified 504 genes
significantly altered in the hippocampus of miR-17-92 KO
mice (false discovery rate <0.1). Among them, 229 genes were
upregulated, suggesting that they are usually directly or
indirectly silenced by miR-17-92, and 78 out of 229 genes
were predicted targets of miR-17-92 (Table S1). Gene ontology
(GO) analyses of the 504 genes with altered expression in miR-
17-92 KO hippocampus revealed that many of them regulate
cell proliferation and differentiation (Figure S4A). This finding isconsistent with the function associated with the 229 upregulated
genes, including predicted targets of the miR-17-92 cluster
(Figure S4B).
Moreover, using four target prediction tools (Targetscan,
miRDB, DIANA-microT, and TarBase), we identified 150 genes,
which are either up- or downregulated, as predicted targets of
the miR-17-92 cluster (Table S1). Interestingly, a detailed GO
analysis of the 150 predicted target genes revealed their involve-
ment in glucocorticoid-related functions in the absence of miR-
17-92 (Figure 4B). Among them, the kinase Sgk1 (Lang et al.,
2010) was found to have a significant upregulation in the miR-
17-92 KO hippocampus (1.3 fold increase) and to be involved
in six out of the top ten predictable major biological functions
that are associated with the 150 target genes (Figure 4B). Sgk1
is known as a downstream effector of the glucocorticoid recep-
tor (GR) (Anacker et al., 2013). Functional interaction analysis of
Sgk1 with 504 genes that showed altered expression in themiR-
17-92 KO hippocampus further indicated that Sgk1, as a crucial
modulator in the glucocorticoid pathway, interacts with genes
directly involved in cell-cycle control, developmental process,
and neurogenesis (Figure 4C). Our results indicate the regulatory
effect of the miR-17-92 cluster on the glucocorticoid pathway.Cell Reports 16, 1653–1663, August 9, 2016 1657
Figure 5. Sgk1 Is a Target of miR-17-92 in
the Adult Hippocampus
(A) The 30 UTR of Sgk1 contained targeting sites for
miR-19a and miR-92a.
(B) Luciferase fused to Sgk1 30 UTR was used to
examine targeting effects of miR-19a and miR-92a
on the Sgk1 30 UTR. Both miR-19a and miR-92a,
but not their mutants (miR-19-mut and miR-92-
mut), recognized the 30 UTR of Sgk1 and reduced
the luciferase activity. n = 3.
(C) Sgk1 (green) expression in the dentate gyrus in
the hippocampus of the 13-week-old wild-type
(WT) and miR-17-92 knockout (KO) mice. Scale
bar, 100 mm.
(D) High power view of highlighted areas in (C).
Arrows indicate Sgk1+ cells in the subgranular
zone (SGZ). Scale bar, 20 mm.
(E) The number of Sgk1+ cells was significantly
increased in the SGZ in miR-17-92 KO mice,
compared to WT controls. n = 6.
DAPI (blue) was used to label nucleus. All data
were presented as means ± SEM. **p < 0.01. A
two-tailed, unpaired Student’s t test was used for
comparisons. See also Figure S5.TheExpression Level of Sgk1 Is Specifically Increased in
miR-17-92 KO Hippocampus
To further test whether Sgk1 is a target of the miR-17-92 cluster,
we searched the Sgk1 30 UTR, where miRNAs typically bind to
silence target gene expression. We found that Sgk1 30 UTR con-
tains binding sites for miR-19a and miR-92a (Figure 5A). We
cloned the Sgk1 30 UTR into a luciferase vector. When the
Sgk1 30 UTR-luciferase was co-expressed with miR-19a or
miR-92a, wild-type, but not their mutants, significantly reduced
the relative luciferase activity, suggesting that miR-19a and
miR-92a have specific targeting effects on the Sgk1 30 UTR
(Figure 5B).
We next examined the expression of Sgk1 in the DG of 13-
week-old wild-type and miR-17-92 KO mice. Scattered Sgk1+
cells were observed in the subgranular zone (SGZ) and the
granule cell layer (GCL) in the DG of wild-type and miR-17-92
KO hippocampus (Figure 5C). Interestingly, the number of
Sgk1+ cells was significantly increased in the SGZ in miR-17-
92 KO mice (Figures 5D and 5E). Moreover, Sgk1+ cells were1658 Cell Reports 16, 1653–1663, August 9, 2016also detected in the polymorphic layer
(PML) (Scharfman and Myers, 2013), the
area between the upper and lower GCLs
(Figure S5A). The number of Sgk1+ cells
also was increased in the PML in miR-
17-92 KO mice (Figures S5B and S5C).
However, the number of cells expressing
GR, an upstream gene of Sgk1 (Anacker
et al., 2013), did not show significant dif-
ference in the DG of control and miR-17-
92 KOmice (Figures S5D and S5E). These
results, consistent with RNA-seq data,
indicate that miR-17-92 knockout in neu-
ral progenitors results in elevated level of
Sgk1 expression in the DG.
To test whether the number of Sgk1+ cells also is increased in
other brain regions in miR-17-92 KO mice, we examined Sgk1
expression in the amygdala, prefrontal cortex, and hypothala-
mus. Sgk1 expression was detected in the amygdala, but the
number of Sgk1+ cells did not show detectable change between
WT control andmiR-17-92 KOmice (Figure 6A). In addition, Sgk1
expression was not detected in the prefrontal cortex and hypo-
thalamus (Figures 6B and 6C). Moreover, the overall neurogene-
sis, labeled by NeuN+ cells, also did not show significant
changes in the amygdala, prefrontal cortex, and hypothalamus
(Figure 6). Our results suggest that elevated expression of
Sgk1 in the hippocampus in miR-17-92 KO mice is brain region
specific.
miR-17-92 Rescues Stress-Induced Proliferation Defect
in Hippocampal Neural Progenitors
A large body of studies has shown that chronic stress alters the
release of adrenal glucocorticoid hormones and in turn affects
hippocampal neurogenesis and has a detrimental influence on
Figure 6. Sgk1 Expressions Are Not Changed in Other Brain Regions in miR-17-92 KO Mice
(A) Sgk1-expressing cells were detected in the amygdala. The numbers of Sgk1+ and NeuN+ cells did not show significant difference between 13-week-old wild-
type (WT) and miR-17-92 knockout (KO) mice.
(B and C) No Sgk1 expressing cells were detected in the prefrontal cortex and hypothalamus. The number of NeuN+ cells did not show significant difference
between WT and miR-17-92 KO mice.
Scale bars, 100 mm. DAPI (blue), Sgk1 (green), and NeuN (red) were labeled. All data were presented asmeans ± SEM. A two-tailed, unpaired Student’s t test was
used for comparisons.learning andmemory andmood behaviors (Joe¨ls, 2008;McEwen,
2001; Saaltink and Vreugdenhil, 2014; Schoenfeld and Gould,
2012). Because we found that miR-17-92 regulates the glucocor-
ticoid pathway, we next examined whether chronic stress also
has a direct effect on miR-17-92 expression in the hippocampus.
Eight-week-old mice were subjected to restraint stress for
2 weeks, while being administered an antidepressant (antidep)
fluoxetine or vehicle as a control (Seo et al., 2012). Consistent
with previous reports (Anacker et al., 2013; Saaltink and Vreug-
denhil, 2014), expression levels of GR and Sgk1 were increaseddue to stress and rescued by antidepressant treatment (Fig-
ure S6A). On the contrary, chronic stress significantly reduced
expression levels of miR-17, miR-18, miR-19a, and miR-92a in
the hippocampus, compared to their controls, and the reduction
was prevented by antidepressant treatment (Figure S6B). These
results suggest that hippocampal expression of miR-17-92 is
responsive to chronic stress and antidepressant.
To further test the effect of miR-17-92 on proliferation of hip-
pocampal neural progenitors under stress treatment, we used
HT-22 cells, which are immortalized mouse hippocampalCell Reports 16, 1653–1663, August 9, 2016 1659
Figure 7. miR-17-92 Mediates Antidepres-
sant- and Stress-Regulated Adult Hippo-
campal Neurogenesis In Vivo
(A–C) The number of Ki67+ (red) progenitors in
the dentate gyrus (DG) was significantly increased
in antidepressant-treated 13-week-old wild-type
(WT) mice, compared to vehicle-treated WT mice.
Moreover, the number of Ki67+ progenitors in the
DG was significantly increased in antidepressant-
treated 13-weeks-old miR-17-92 knockout (KO)
mice, compared to vehicle-treated miR-17-92 KO
mice.
(D) miR-17-92 KO mice showed less degree of in-
crease in the number of Ki67+ progenitors in the
DG than WT mice after antidepressant treatment.
(E–G) The number of Ki67+ progenitors in the DG
was significantly reduced in stress-administered
13-week-old WT mice, compared to WT mice
without stress treatment. However, stress-admin-
istered miR-17-92 overexpressing (OE) mice
showed significant rescue of reduced number of
Ki67+ progenitors.
(H) miR-17-92 OE mice showed less degree of
decrease in the number of Ki67+ progenitors in the
DG than WT mice after stress treatment.
Scale bars, 100 mm. DAPI (blue) was used to label
nucleus. All data were presented as means ± SEM,
n = 6 per group. *p < 0.05, **p < 0.01, ***p < 0.001;
n.s., not significant. Statistical analyses were as-
sessed using two-way ANOVA with Bonferroni’s
post hoc test. See also Figures S6 and S7.neurons (Davis and Maher, 1994). HT-22 cells were treated with
corticosterone (CORT) and the vehicle control (Malviya et al.,
2013) and were then transfected with the pCAGIG vector con-
taining a GFP reporter gene and pulsed with BrdU for 2 hr.
CORT-treatment significantly reduced BrdU+/GFP+ cells, com-
pared to the vehicle control (Figures S6C and S6D). Furthermore,
miR-19a and miR-92a precursors were cloned into the pCAGIG
vector and transfected into CORT-treated HT-22 cells (Bian
et al., 2013). Compared to those transfected with the empty
pCAGIG vector, BrdU+/GFP+ cells were significantly increased1660 Cell Reports 16, 1653–1663, August 9, 2016upon miR-19a and miR-92a transfection
(Figures S6C and S6D). These results
suggest that miR-19a and miR-92a in
the miR-17-92 cluster rescues prolifera-
tion defect in hippocampal neural progen-
itors caused by corticosterone.
miR-17-92 Mediates
Antidepressant- and Stress-
Regulated Adult Hippocampal
Neurogenesis In Vivo
We found that miR-17-92 KO and OE
mice show altered hippocampal neuro-
genesis. We wanted to examine whether
there is a direct causal relationship be-
tween miR-17-92 expression and hippo-
campal neurogenesis defects. Previous
studies have shown that antidepressanttreatment has a positive impact on adult hippocampal neuro-
genesis (Boldrini et al., 2009; Malberg et al., 2000). We then
tested whether antidepressant-regulated neurogenesis is
mediated by miR-17-92. Wild-type control and miR-17-92
KO mice were administered the antidepressant fluoxetine for
2 weeks. Consistent with previous reports, elevated neurogen-
esis was observed in control and miR-17-92 KO hippocampus
(Figures 7A–7C). However, the degree of increased neuro-
genesis was significantly restrained by miR-17-92 knockout
(Figure 7D).
Furthermore, studies have shown that chronic stress has a
negative effect on hippocampal neurogenesis (Joe¨ls, 2008;
McEwen, 2001; Saaltink and Vreugdenhil, 2014; Schoenfeld
and Gould, 2012). We next examined whether overexpression
of miR-17-92 protects stress-induced decrease of adult hippo-
campal neurogenesis. Wild-type control and miR-17-92 OE
mice at 8weeks oldwere subjected to restraint stress for 2weeks
(Seo et al., 2012). While stress caused a reduction in neurogen-
esis in the control hippocampus, its effect onmiR-17-92 OE hip-
pocampus was subtle, suggesting that overexpression of miR-
17-92 rescues stress-induced neurogenesis defect (Figures
7E–7H).
Sgk1 Expression Displays an Opposite Change
Compared to Hippocampal Neurogenesis upon
Antidepressant and Stress Treatment
If miR-17-92-mediated adult hippocampal neurogenesis is partly
regulated through their target gene Sgk1, changes in Sgk1
expression and neurogenesis should be opposite. We examined
Sgk1 expression in the hippocampus of wild-type control and
miR-17-92 KO mice that are administered the antidepressant
fluoxetine. In the control hippocampus treated with antidepres-
sant, the number of Sgk1+ cells was not altered compared to un-
treated (Figure S7A). Moreover, while antidepressant treatment
resulted in an increased neurogenesis (Figures 7A–7D), it caused
decreased number of Sgk1+ cells in miR-17-92 KO hippocam-
pus, compared to untreated miR-17-92 KO (Figure S7A).
Furthermore, while chronic stress caused a decreased neuro-
genesis in the control hippocampus (Figures 7E–7H), it caused
an increase in the number of Sgk1+ cells (Figure S7B). Interest-
ingly, inmiR-17-92 OEmice treated with stress, miR-17-92 over-
expression prevented a reduction in neurogenesis (Figures 7E–
7H), it caused a decrease in the number of Sgk1+ cells, which
further suggests a silencing effect of miR-17-92 on Sgk1 expres-
sion (Figure S7B). Moreover, miR-17-92 knockout caused a dra-
matic increase in the number of Sgk1+ cells in the hippocampus
ofmiR-17-92 KOmice (Figure S7B). These results indicate miR-
17-92 targeting effect on Sgk1 in vivo.
Because increased neurogenesis and decreased Sgk1
expression were detected in the hippocampus of miR-17-92
KO mice treated with antidepressant, we further examined the
behavioral outcome. The forced swim test and tail suspension
test were performed in miR-17-92 KO mice treated with vehicle
and antidepressant. miR-17-92 KO mice treated with antide-
pressant displayed reduced immobility time in both tests,
compared to those treated with vehicle, suggesting that antide-
pressant treatment has a rescue effect on depression-like be-
haviors in miR-17-92 KO mice (Figures S7C and S7D).
DISCUSSION
Identification of specific molecules that regulate anxiety- and
depression-like behaviors would contribute to our better under-
standing of pathophysiology of mood and anxiety disorders. In
this study, we have shown that miRNAs in the miR-17-92 cluster
are highly expressed in the adult mouse hippocampus. Impor-
tantly, deletion or overexpression of miR-17-92 in adult neural
progenitors causes decreased or increased hippocampal neuro-genesis, resulting in elevated anxiety- and depression-like be-
haviors, or anxiolytic and antidepression-like behaviors, respec-
tively. Our results suggest a molecular mechanism by which
miRNAs are associated with adult hippocampal neurogenesis
and mood and depression-like behaviors.
Adult hippocampal neurogenesis requires multiple steps,
including proliferation of neural progenitors, differentiation to neu-
rons, and survival of newborn neurons (Ming and Song, 2011;
Zhao et al., 2008). Our results have shown that miR-17-92 plays
a role in the maintenance of proliferative neural progenitors and
the generation of newborn neurons. The role for miR-17-92 in
the proliferation of neural progenitors in the adult hippocampus
is consistent with its demonstrated function in the maintenance
of embryonic neural stem cells and the proliferation of various
cancer cells (Bian et al., 2013; Olive et al., 2010). We have found
that miR-17-92 knockout causes a reduction of antidepressant-
induced increase in neurogenesis, while miR-17-92 overexpres-
sion is resistant to stress-induced reductions in neurogenesis,
indicating a direct role of miR-17-92 in regulating hippocampal
neurogenesis.Moreover, here, we have identified that the expres-
sion levels of multiple genes, known to be involved in cell prolifer-
ation and differentiation, are altered in the hippocampus of miR-
17-92 KOmice. Particularly, the alterations in the level of multiple
genes that are implicated in glucocorticoid-mediated pathways
are also observed in the hippocampus of miR-17-92 KO mice.
Because glucocorticoid and its signaling are known to affect adult
hippocampal neurogenesis (Joe¨ls, 2007), altered expression of
target genes for miR-17-92 in glucocorticoid pathways may be
responsible for impaired adult neurogenesis in miR-17-92 KO
mice. Future studies should address which target genes for
miR-17-92 contribute to which specific steps of the adult
neurogenesis.
Recent studies have suggested an involvement of miRNAs in
the regulation of anxiety- and depression-like behaviors. miR-
16 was found to play a role in the actions of the selective seroto-
nin reuptake inhibitor (SSRI) by targeting the serotonin trans-
porter in serotonergic and noradrenergic neurons (Baudry
et al., 2010). miR-135 was shown to target serotonin transporter
and serotonin receptor-1a in the serotonergic neurons and regu-
late anxiety- and depression-like behaviors and behavioral
response to antidepressant treatment (Issler et al., 2014). miR-
18 might negatively regulate the glucocorticoid pathway (Shi-
mizu et al., 2015; Vreugdenhil et al., 2009). Glucocorticoid is
associated with stress-induced anxiety and mood behaviors
(McEwen, 2001; Pace and Miller, 2009). Previously, the
increased level of Sgk1 was observed in peripheral blood of
depressed patients (Anacker et al., 2013). In this study, we
have identified Sgk1 as a direct target of miR-19a and miR-92a
in the miR-17-92 cluster in vitro and in vivo. The increased
Sgk1 expression, as a result of miR-17-92 deletion, was
observed in the SGZ of the DG, but not in other brain regions.
It is possible that the effects ofmiR-17-92 deletion in hippocam-
pal neurogenesis and mouse behaviors are, at least in part,
mediated by increased Sgk1.
Furthermore, although we observed a correlation between the
altered hippocampal neurogenesis and behavioral phenotypes
inmiR-17-92 KO or OEmice, the connection of adult hippocam-
pal neurogenesis to anxiety- and depression-like behaviorsCell Reports 16, 1653–1663, August 9, 2016 1661
remains controversial (Petrik et al., 2012; Samuels and Hen,
2011; Snyder et al., 2011). Nevertheless, because miRNAs are
useful tools for the treatment of mood and anxiety disorders
(O’Connor et al., 2012), the causal relationship observed in this
study between altered levels of miR-17-92 and anxiety- and
depression-like behaviors suggests that the miR-17-92 cluster
has potential as a therapeutic target for these disorders.
EXPERIMENTAL PROCEDURES
Transgenic Mouse Lines
To delete the miR-17-92 cluster in the adult mouse brain, floxed miR-17-92
transgenic mice (Ventura et al., 2008) (requested from the lab of Dr. Tyler
Jacks, MIT, USA) were bred with the tamoxifen-inducible Nestin-Cre line,
called Nestin-CreERtm mice (Kuo et al., 2006) (requested from the lab of Dr.
Yuh-Nung Jan, UCSF, USA), to generate miR-17-92flox/flox:Nestin-CreER.
miR-17-92 KO mice were generated after the injection of tamoxifen. To over-
express themiR-17-92 cluster in the adult brain, we employed transgenic mice
with a floxed stop codon in front of themiR-17-92 transgene (Xiao et al., 2008).
Once bred with the Nestin-CreER line, the overexpression of the miR-17-92
cluster was induced by tamoxifen, called here miR-17-92 overexpressing
(OE) mice. Wild-type mice used in this project were mice that carry homozy-
gote floxed alleles but are Cre-negative. Tamoxifen was administered all gen-
otyping mice to avoid tamoxifen drug effect.
Transgenic animals were maintained at the facility of Weill Cornell Medical
College. Animal use was overseen by the Animal Facility and approved by
the Institutional Animal Care and Use Committee (IACUC) at the Weill Cornell
Medical College. Experiments with chronic restraint stress were performed at
The Rockefeller University, and the experimental procedure was approved by
The Rockefeller University Institutional Animal Care and Use Committee and
was in accordance with guidelines of the NIH.
RNA-Seq
The adult hippocampi of the 13-week-oldmicewere dissected from threewild-
type and three miR-17-92 KO mice, each of them from a different litter. Total
RNAwas extracted and purified using the RNeasymini kit with optional on-col-
umn DNase digestion (QIAGEN). Whole RNA-seq was performed at the Weill
Cornell Genomics Core Facility using an IlluminaHiseq 1000.
Statistics
All data were shown as means ± SEM. Two group comparisons were done by
two-tailed, unpaired Student’s t test. The influence of drug and stress treat-
ment was assessed using two-way ANOVA with Bonferroni’s post hoc tests.
Additional experimental procedures and associated references are available
in the Supplemental Experimental Procedures.
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